Continuation of Milnacipran Therapy During Pregnancy in a Patient with Severe PTSD and Psychotic Depression: A Case Study with Three-Year Pediatric Outcomes - Top-Institutions - MDSpire

Continuation of Milnacipran Therapy During Pregnancy in a Patient with Severe PTSD and Psychotic Depression: A Case Study with Three-Year Pediatric Outcomes

By
Maximilian Preiss
Lucie Bartova
April 27, 2026
0 min

Frontiers In Psychiatry

Share

Top Institutions in Psychiatry

Brief introduction explaining scope and methodology.

#1

Massachusetts General Hospital

Boston, MA
Key Differentiators
- Perinatal Psychiatry
- Psychopharmacology
- Maternal-Fetal Medicine
#2

University of North Carolina at Chapel Hill

Chapel Hill, NC
Key Differentiators
- Perinatal Psychiatry
- Psychopharmacology
- Epidemiology
#3

University of California, San Francisco

San Francisco, CA
Key Differentiators
- Perinatal Psychiatry
- Psychopharmacology
- Neonatology
#4

Columbia University Irving Medical Center

New York, NY
Key Differentiators
- Perinatal Psychiatry
- Psychopharmacology
- Child Psychiatry
#5

Johns Hopkins University

Baltimore, MD
Key Differentiators
- Perinatal Psychiatry
- Psychopharmacology
- Maternal-Fetal Medicine

Original Source(s)

Frontiers In Psychiatry

Continuation of Milnacipran Therapy During Pregnancy in a Patient with Severe PTSD and Psychotic Depression: A Case Study with Three-Year Pediatric Outcomes

by Maximilian Preiss, Lucie Bartova
April 27, 2026

Related Content

Frontiers In Psychiatry

From cats to cortex: T. gondii and psychosis, depression, and anxiety

by Gabriel Andrade, Abderrahim Benlahcene, Dalia Bedewy
May 13, 2026

Jama Psychiatry

Transdiagnostic Patterns of Grip Strength in Schizophrenia, Current Depression, and Remitted Depression

Frontiers In Psychiatry

Application of a Cognitive-Structure Framework-Based Scenario-Based Education Programme in Schizophrenia Patients with Delusional Symptoms: A Randomised Controlled Trial